Anavex Life Sciences Corp.AVXLNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-51.41M
↓ 42% below average
Average (9y)
$-36.31M
Historical baseline
Range
High:$-15.54M
Low:$-55.76M
CAGR
+14.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-51.41M | +2.8% |
| 2024 | $-52.88M | +5.2% |
| 2023 | $-55.76M | -9.4% |
| 2022 | $-50.99M | -21.6% |
| 2021 | $-41.92M | -34.8% |
| 2020 | $-31.09M | -8.1% |
| 2019 | $-28.75M | -49.9% |
| 2018 | $-19.18M | -23.5% |
| 2017 | $-15.54M | +0.3% |
| 2016 | $-15.59M | - |